Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016
- PMID: 31509593
- PMCID: PMC6738602
- DOI: 10.1371/journal.pone.0222423
Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016
Abstract
Background: Respiratory diseases, including pneumonia, are the second largest cause of under-five mortality in Mongolia and the most common cause of childhood hospitalization. However information regarding the contribution of Streptococcus pneumoniae to pneumonia causation in Mongolia is limited. We aimed to describe the epidemiology of hospitalized children aged 2-59 months with pneumonia, enrolled into a surveillance program in the period prior to pneumococcal conjugate vaccine (PCV) introduction, in Mongolia.
Methods: An expanded pneumonia surveillance program enrolled children, who met the surveillance case definition, at participating hospitals, between April 2015 and May 2016. Cumulative incidence rates were calculated by district for all pneumonia endpoints using district specific denominators from the Mongolian Health Department census for 2016. Socio-economic and disease-associated factors were compared between districts using chi-squared tests.
Results: A total of 4318 eligible children with pneumonia were enrolled over the 14 month period. Overall the incidence for all-cause pneumonia in children aged 12-59 months was 31.8 per 1000 population; children aged 2-11 months had an almost four-fold higher incidence than children aged 12-59 months. Differences were found between districts with regards to housing type, fuel used for cooking, hospital admission practices and the proportions of severe and primary endpoint pneumonia.
Discussion: This study shows a high burden of pneumonia in children aged 2-59 months in Mongolia prior to PCV introduction. Rates differed somewhat by district and age group and were influenced by a number of socio-economic factors. It will be important to consider these differences and risk factors when assessing the impact of PCV introduction.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2-59 months in Mongolia: an active pneumonia surveillance programme.Lancet Microbe. 2024 Dec;5(12):100929. doi: 10.1016/S2666-5247(24)00171-X. Epub 2024 Oct 30. Lancet Microbe. 2024. PMID: 39486429
-
Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study.BMC Public Health. 2021 Sep 23;21(1):1731. doi: 10.1186/s12889-021-11776-8. BMC Public Health. 2021. PMID: 34556065 Free PMC article.
-
Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned.BMC Public Health. 2019 Mar 21;19(1):333. doi: 10.1186/s12889-019-6639-y. BMC Public Health. 2019. PMID: 30898094 Free PMC article.
-
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.Hum Vaccin Immunother. 2016;12(2):314-25. doi: 10.1080/21645515.2015.1084450. Hum Vaccin Immunother. 2016. PMID: 26317537 Free PMC article. Review.
-
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.J Glob Health. 2023 Feb 3;13:05002. doi: 10.7189/jogh.13.05002. J Glob Health. 2023. PMID: 36734192 Free PMC article.
Cited by
-
Impact assessment of a raw coal ban on maternal and child health outcomes in Ulaanbaatar: a protocol for an interrupted time series study.BMJ Open. 2023 Apr 24;13(4):e061723. doi: 10.1136/bmjopen-2022-061723. BMJ Open. 2023. PMID: 37094900 Free PMC article.
-
Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.Emerg Infect Dis. 2024 Mar;30(3):490-498. doi: 10.3201/eid3003.230864. Emerg Infect Dis. 2024. PMID: 38407131 Free PMC article.
-
Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study.Lancet Reg Health West Pac. 2021 Jul 30;15:100231. doi: 10.1016/j.lanwpc.2021.100231. eCollection 2021 Oct. Lancet Reg Health West Pac. 2021. PMID: 34528012 Free PMC article.
-
Socioeconomic inequalities in health problems in the first two years of life: Pelotas (Brazil) birth cohort, 2015.Cad Saude Publica. 2024 Oct 18;40(10):e00208022. doi: 10.1590/0102-311XEN208022. eCollection 2024. Cad Saude Publica. 2024. PMID: 39442160 Free PMC article.
-
Epidemiology of pneumonia in hospitalized adults ≥18 years old in four districts of Ulaanbaatar, Mongolia, 2015-2019.Lancet Reg Health West Pac. 2022 Sep 10;30:100591. doi: 10.1016/j.lanwpc.2022.100591. eCollection 2023 Jan. Lancet Reg Health West Pac. 2022. PMID: 36419739 Free PMC article.
References
-
- Sonego M, Pellegrin MC, Becker G, Lazzerini M. Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10(1):e0116380 10.1371/journal.pone.0116380 - DOI - PMC - PubMed
-
- Centre for Health Development. Health Indicators 2016. Ulaanbaater 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous